Inclusion Is the New Standard: Biopharma’s Push for More Representative Clinical Trials
As clinical trials evolve, one thing is certain: representativeness is no longer a nice-to-have; it’s a non-negotiable. The data are clear. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, 84% reported ramping up efforts to improve...
ISPE to Impact: Shaping the Next Era of Pharmacoepidemiology with Real-World Data
Reflecting on the discussions from this year’s International Society for Pharmacoepidemiology (ISPE) Annual Meeting and looking ahead to the future of the field, I’m struck by the steady but significant evolution pharmacoepidemiology is undergoing driven in large part...
From Buzz to Breakthrough: How Biopharma Is Embedding Real-World Data into Drug Development
In just a few years, real-world data (RWD) has evolved from an industry buzzword to a core driver of progress in drug development. What used to be experimental is now operational and increasingly essential. In the 2025 TriNetX and studioID survey of 150 senior...
New TriNetX Research Impact Report Illuminates How Real-World Data is Fueling Rare Disease Innovation
Analysis reveals strategic opportunities for pharmaceutical leaders to close treatment gaps and accelerate breakthroughs in underserved rare disease communities. Cambridge, MA, July 31, 2025 — TriNetX, driven by its vision of a connected world where data and...
Elevating Research and Patient Care: How HCOR – Associação Beneficente Síria is Advancing Innovation Through Real-World Data
In an era where real-world data (RWD) is rapidly transforming clinical research, one organization is harnessing this potential to shape the future of healthcare in Brazil and beyond. HCOR – Associação Beneficente Síria, a renowned healthcare institution based in São...
New TriNetX Survey Reveals Biopharma’s Bold Embrace of Real-World Data and Artificial Intelligence—But Warns of Looming Barriers
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum. CAMBRIDGE, MA – July 10, 2025 – As...
From Protocol Design to Execution: How Real-World Data Accelerates Clinical Trial Completion
Download the Infographic Discover how Real-World Data Accelerates Clinical Trial Completion Clinical trials often falter at the final stretch—when it’s time to execute. It’s here that well-intentioned protocols meet real-world complexity, where timelines can...
Cracking the Code on the Last Mile: A Three-Step Process for Clinical Trial Success
In the high-stakes world of clinical research, innovation doesn’t just happen in the lab; it must cross the clinical trial finish line of regulatory submission. Yet for many sponsors, sites, and researchers, patient recruitment—or the “last mile”—remains a costly...